Global In-Vitro Fertilization Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & Accessories.By Type;
Conventional IVF, and IVF with ICSI.By Procedure;
Fresh Donor and Frozen Donor.By Providers;
Fertility Clinics, and Hospitals & Others Setting.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global In-Vitro Fertilization Market (USD Million), 2021 - 2031
In the year 2024, the Global In-Vitro Fertilization Market was valued at USD 7,143.49 million. The size of this market is expected to increase to USD 12,809.07 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
Global In-Vitro Fertilization Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 8.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 8.7 % |
Market Size (2024) | USD 7,143.49 Million |
Market Size (2031) | USD 12,809.07 Million |
Market Concentration | Medium |
Report Pages | 308 |
Major Players
- Cooper Companies Inc.
- Cook Group
- Vitrolife
- Thermo Fisher Scientific, Inc.
- Esco Micro Pte. Ltd.
- Genea Limited
- IVFtech ApS
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global In-Vitro Fertilization Market
Fragmented - Highly competitive market without dominant players
The global in vitro fertilization (IVF) market is growing rapidly due to the rising prevalence of infertility and the increasing demand for advanced reproductive solutions. Around 15% of couples worldwide face infertility challenges, boosting the adoption of IVF as an effective treatment option. IVF success rates have improved with technological advancements, and over 45% of treatments are now sought by individuals over 35, driven by later-life childbearing trends.
Rising Awareness and Demand for Fertility Treatments
Growing awareness of fertility solutions has accelerated IVF adoption, especially as more patients look for personalized treatment plans. With technological breakthroughs like genetic screening and embryo freezing, success rates have increased by 40-45%, further fueling market demand.
Fertility Tourism Driving Market Growth
Fertility tourism is on the rise as patients seek more affordable IVF options abroad, representing an expected 25% of the market. This growing trend contributes to market expansion and diversifies IVF access worldwide.
Regulatory and Ethical Advancements Supporting Market Growth
Government regulations and insurance coverage for IVF treatments are making fertility care more accessible, with 20-30% of patients utilizing insurance to ease costs. These policy changes are expected to broaden IVF treatment accessibility, enhancing the market’s overall growth.
Global In-Vitro Fertilization Market Recent Developments
-
In January 2022, Ferring Pharmaceuticals announced the acquisition of Merck’s global in vitro fertilization (IVF) business. This strategic move is expected to strengthen Ferring’s position in the IVF market by enhancing its portfolio of fertility treatments and technologies. By acquiring Merck’s IVF assets, Ferring aims to expand its capabilities in offering comprehensive reproductive healthcare solutions. This acquisition marks a significant step in Ferring’s ongoing commitment to advancing fertility care and supporting couples worldwide in their journey to parenthood.
-
In February 2022, AbbVie and SpringWorks Therapeutics formed a strategic collaboration aimed at developing innovative IVF treatments for infertility. This partnership combines AbbVie’s expertise in pharmaceutical development with SpringWorks’ capabilities in clinical research, focusing on enhancing fertility treatment options. The collaboration is expected to accelerate the development of advanced solutions to address infertility, further expanding both companies’ contributions to the growing IVF market.
Segment Analysis
In this report, the Global In-Vitro Fertilization Market has been segmented by Product, Type,Procedure, Providers, and Geography.
Global In-Vitro Fertilization Market, Segmentation by Product
The Global In-Vitro Fertilization Market has been segmented by Product into Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & Accessories.
Micromanipulators
Micromanipulators are crucial tools in the in-vitro fertilization (IVF) market, accounting for a significant share of approximately 25%. These precision instruments are essential for manipulating eggs and sperm during the IVF process, ensuring accurate fertilization. The demand for micromanipulators is expected to increase with the growing number of IVF procedures and the continuous advancements in reproductive technologies.
Incubators
Incubators are vital for the growth and development of embryos during the IVF process. This segment represents around 20% of the market. With technological innovations in incubator systems, such as time-lapse monitoring, the IVF success rate has improved significantly. As more fertility clinics adopt these advanced incubators, the segment is expected to experience steady growth, driven by the increasing demand for high-quality fertility treatments.
Cabinets
Cabinets play a significant role in maintaining the ideal storage conditions for eggs, embryos, and sperm in IVF labs. This segment accounts for approximately 15% of the IVF market. As the need for sterile and controlled environments rises, the demand for high-performance cabinets designed for IVF applications is growing. Cabinets that provide precise temperature and humidity control are essential for ensuring the success of IVF procedures.
Imaging System
Imaging systems, including ultrasound and advanced 3D imaging technologies, hold a substantial share of the IVF market, accounting for around 18%. These systems are crucial for monitoring embryo development and assessing the quality of eggs and sperm during IVF. With advancements in imaging technologies, such as enhanced resolution and real-time monitoring, the market is witnessing an increase in demand for these systems to improve IVF outcomes.
Laser System
Laser systems in the IVF market represent approximately 12% of the overall market share. These systems are widely used for procedures such as embryo hatching and sperm DNA fragmentation. The demand for laser systems is expected to rise as advancements in laser technologies continue to improve IVF success rates, leading to better outcomes for patients undergoing assisted reproductive treatments.
Reagents & Accessories
Reagents and accessories are fundamental to the IVF process and account for around 10% of the global IVF market. These products, including culture media, reagents, and petri dishes, are essential for supporting embryo growth and fertilization. As IVF procedures become more sophisticated, the demand for high-quality reagents and accessories is growing to ensure optimal results for patients undergoing treatment.
Global In-Vitro Fertilization Market, Segmentation by Type
The Global In-Vitro Fertilization Market has been segmented by Type into Conventional IVF, and IVF with ICSI.
Conventional IVF
Conventional IVF is a traditional fertilization technique in which sperm and eggs are combined in a petri dish, allowing natural fertilization to occur. It is widely used in cases where there are no severe male infertility issues and contributes to around 40% of global IVF treatments. Its cost-effectiveness and non-invasive nature make it a preferred first-line treatment for many patients.
IVF with ICSI
IVF with ICSI (Intracytoplasmic Sperm Injection) has become the leading choice in modern fertility treatments, accounting for about 60% of all IVF procedures. This method involves directly injecting a single sperm into the egg, significantly increasing the chances of fertilization, especially in cases of male infertility. Its high success rate and applicability in complex cases drive its widespread adoption.
Global In-Vitro Fertilization Market, Segmentation by Procedure
In this report, the Global In-Vitro Fertilization Market has been segmented by Procedure into Fresh Donor, Frozen Donor, Fresh Non-Donor, and Frozen Non-Donor.
Fresh Donor
Fresh donor IVF procedures, making up about 15% of the market, involve the use of freshly harvested eggs from a donor for immediate fertilization and embryo transfer. This method is known for slightly better success rates due to the freshness of the eggs, although it requires close timing between donor and recipient cycles.
Frozen Donor
Accounting for around 25% of IVF treatments, frozen donor procedures offer enhanced flexibility and scheduling. By using previously frozen donor eggs, clinics can reduce the coordination burden and improve patient convenience. Advances in cryopreservation have significantly boosted the effectiveness of this method
Global In-Vitro Fertilization Market, Segmentation by Providers
In this report, the Global In-Vitro Fertilization Market has been segmented by Providers into Fertility Clinics, and Hospitals & Others Setting
Fertility Clinics
Fertility clinics represent the largest share of IVF services globally, capturing nearly 65% of the market. These centers are equipped with specialized technology and expert teams that focus exclusively on reproductive care, enabling higher success rates and customized treatment approaches. Their patient-centric services make them the primary choice for many undergoing IVF.
Hospitals & Others Setting
Hospitals and other care settings hold approximately 35% of the IVF provider market. They offer integrated medical care and are well-suited for patients with complex health conditions. These institutions combine IVF services with broader healthcare infrastructure, offering comprehensive support for those with coexisting medical needs.
Global In-Vitro Fertilization Market, Segmentation by Geography
In this report, the Global In-Vitro Fertilization Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global In-Vitro Fertilization Market Share (%), by Geographical Region, 2024
North America
North America dominates the IVF landscape, contributing around 35% to the global market. The region benefits from cutting-edge fertility technologies, comprehensive insurance coverage, and a growing number of fertility centers offering advanced reproductive services.
Europe
Holding close to 30% of the IVF market, Europe boasts a mature healthcare system and supportive fertility policies. Increased maternal age and access to public and private fertility services are major growth factors across the region.
Asia Pacific
With an approximate 20% market share, Asia Pacific stands out as the fastest-growing IVF market. Factors such as rising healthcare expenditure, growing fertility awareness, and the emergence of international IVF centers are boosting regional growth.
Middle East and Africa
Middle East and Africa account for nearly 8% of the global IVF market. The rise in infertility rates, coupled with increasing openness toward fertility treatments, is enhancing demand for assisted reproduction across this region.
Latin America
Latin America captures about 7% of the global IVF market. Improvements in healthcare access, increasing urbanization, and expanding fertility awareness are fostering gradual growth in IVF adoption across the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global In-Vitro Fertilization Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Technological Advancements
- Changing Regulatory Landscape
-
Societal Acceptance - One of the primary drivers behind this societal acceptance is the growing recognition of infertility as a widespread issue affecting millions of individuals and couples globally. As infertility rates rise due to factors such as delayed childbearing, environmental pollutants, lifestyle choices, and medical conditions, there has been a corresponding increase in public awareness and empathy towards those struggling to conceive. This shift in perspective has led to greater advocacy for fertility treatments and support services, reducing the stigma associated with seeking medical assistance for infertility.
Advancements in medical technology and ART procedures have played a pivotal role in enhancing the success rates and safety profile of IVF treatments, further contributing to societal acceptance. As IVF becomes increasingly accessible, affordable, and effective, more individuals and couples are willing to explore fertility treatments as a viable option for starting or expanding their families.
Changing cultural norms and evolving family structures have also influenced societal acceptance of IVF and other fertility treatments. With changing perceptions of parenthood, family-building, and gender roles, there is greater openness to alternative reproductive options, including donor sperm, donor eggs, surrogacy, and adoption, among others. This cultural shift towards inclusivity and diversity in family formation has created a more supportive environment for individuals and couples pursuing IVF treatments.
Restraints:
- High Cost Barrier
- Ethical Concerns
-
Limited Access - Limited access to IVF treatment stems from various factors, including financial barriers, geographic disparities, and healthcare infrastructure constraints. The high cost associated with IVF procedures, including consultation fees, diagnostic tests, medication, and treatment cycles, often renders IVF services financially inaccessible for individuals without adequate insurance coverage or financial means. This financial burden can be exacerbated by the absence of insurance coverage for fertility treatments in many healthcare systems, leaving patients to bear the full cost of treatment out of pocket.
Geographic disparities in access to IVF services also contribute to limited accessibility, particularly in rural or remote areas where specialized fertility clinics may be scarce or nonexistent. In such regions, individuals and couples seeking IVF treatment may face challenges in accessing comprehensive fertility care, including diagnostic assessments, treatment consultations, and ongoing support services. Moreover, disparities in healthcare infrastructure and resources between urban and rural areas can further exacerbate disparities in access to IVF treatment, perpetuating inequities in healthcare delivery.
Sociocultural factors and legal restrictions in certain countries may pose barriers to access to IVF treatment, particularly for marginalized populations or individuals belonging to minority groups. Cultural stigmas surrounding infertility and ART, as well as legal restrictions on reproductive rights and fertility treatments, can deter individuals from seeking IVF services or accessing them discreetly and without discrimination.
Opportunities:
- Emerging Markets Expansion
- Fertility Tourism Growth
-
Genetic Screening Adoption - Genetic screening, also known as preimplantation genetic testing (PGT), involves the analysis of embryos created through IVF to identify genetic abnormalities or chromosomal anomalies before implantation. This screening process enables healthcare providers to select embryos with the highest likelihood of implantation and healthy development, thereby reducing the risk of genetic disorders and improving the chances of a successful pregnancy.
The adoption of genetic screening in the IVF market offers several benefits for patients and healthcare providers alike. Firstly, it provides couples undergoing IVF with valuable information about the genetic health of their embryos, allowing them to make informed decisions regarding embryo selection and family planning. By identifying embryos free from genetic abnormalities, genetic screening minimizes the risk of miscarriage and pregnancy complications, offering reassurance to prospective parents and improving overall pregnancy outcomes.
Genetic screening contributes to the prevention of inherited genetic diseases by enabling the detection and elimination of embryos carrying disease-causing mutations. This proactive approach to genetic screening helps to break the cycle of hereditary conditions within families and reduces the burden of genetic disorders on future generations. Additionally, genetic screening can enhance the efficiency of IVF procedures by optimizing embryo selection and reducing the need for repeated IVF cycles, thereby lowering overall treatment costs and improving patient satisfaction.
Competitive Landscape Analysis
Key players in Global In-Vitro Fertilization Market include:
- Cooper Companies Inc. (US)
- Cook Group (US)
- Vitrolife (Sweden)
- Thermo Fisher Scientific, Inc. (US)
- Esco Micro Pte. Ltd. (Singapore)
- Genea Limited (Australia)
- IVFtech ApS (Denmark)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Procedure
- Market Snapshot, By Providers
- Market Snapshot, By Region
- Global In-Vitro Fertilization Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Technological Advancements
-
Changing Regulatory Landscape
-
Societal Acceptance
-
- Restraints
-
High Cost Barrier
-
Ethical Concerns
-
Limited Access
-
- Opportunities
-
Emerging Markets Expansion
-
Fertility Tourism Growth
-
Genetic Screening Adoption
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
-
Micromanipulators
-
Incubators
-
Cabinets
-
Imaging System
-
Laser System
-
Reagents & Accessories
-
- Global In-Vitro Fertilization Market, By Type, 2021 - 2031 (USD Million)
-
Conventional IVF
-
IVF with ICSI
-
-
Global In-Vitro Fertilization Market, By Procedure, 2021 - 2031 (USD Million)\
-
Fresh Donor
-
Frozen Donor
-
-
Global In-Vitro Fertilization Market, By Providers, 2021 - 2031 (USD Million)
-
Fertility Clinics
-
Hospitals & Others Setting
-
- Global In-Vitro Fertilization Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Cooper Companies Inc.
- Cook Group
- Vitrolife
- Thermo Fisher Scientific, Inc.
- Esco Micro Pte. Ltd.
- Genea Limited
- IVFtech ApS
- Company Profiles
- Analyst Views
- Future Outlook of the Market